Use of Telehealth During the COVID-19 Pandemic Among Practicing Maternal-Fetal Medicine Clinicians


Introduction

COVID-19 has hastened the transition to telehealth to ensure safe, continuous, and effective obstetric care.1–4 According to a national survey, 84% of obstetricians were conducting telehealth visits by June 2020, a jump from 16% prepandemic.3 Telehealth uses computers, mobile, and other remote devices to educate, share information, and provide care to patients without an in-person visit. It can be rendered by text messaging, electronic patient portals, smartphone applications, remote patient monitoring (RPM), remote reading of images, and virtual visits through audio or live video.

The latter allows physicians and patients to see and hear each other in real time.5 Despite widespread use, the average share of live telehealth visits has remained low. Higher shares are reported by Maternal-Fetal Medicine (MFM) providers compared with other obstetric caregivers, and particularly by female physicians, those under age 54, those with prepandemic experience using telehealth, and those practicing in urban locations, in the West and Northeast, and in Medicaid expansion states.3,4

Evidence suggests that telehealth visits compared with in-person visits may yield similar maternal and neonatal outcomes, reinforce healthy behaviors, and improve patient satisfaction.5–11 Nonetheless, several barriers have discouraged provider telehealth use. Barriers include payer policies and lack of reimbursement, as well as technical and connectivity challenges, insufficient provider buy-in, and patient characteristics that place them at a disadvantage for digital health care access.12–15 In contrast, regulatory flexibility regarding Health Insurance Portability and Accountability Act (HIPAA) privacy and consent during the pandemic has enhanced telehealth use.16 In 2020, all states expanded telehealth coverage for their Medicaid populations and several initiatives provided enhanced private coverage.16

Studies that examine the simultaneous contribution of multiple variables associated with uptake and extent of telehealth use in maternity care are scant. Questions remain regarding the drivers of telehealth use during the pandemic among obstetric providers and whether they think that telehealth visits should be integrated into maternity care on a more permanent basis. To address these issues, we followed a conceptual model whereby we assessed the extent of use of live telehealth video visits and its association with predisposing factors (i.e., demographic and clinical practice setting characteristics) and enabling factors (i.e., prepandemic telehealth utilization and perceived structural and patient barriers and enhancers) (Fig. 1). A better understanding of MFM physicians’ utilization patterns, their perceived effectiveness, and intent to use telehealth in the future, will help us monitor access to and use of telehealth visits after the pandemic is contained.

Fig. 1.

Fig. 1. Potential contributors to live video visit use among MFM providers during COVID-19. MFM, Maternal-Fetal Medicine.

Methods

This cross-sectional study drew data from the Society for Maternal-Fetal Medicine (SMFM) Telehealth Survey distributed to U.S.-based regular and associate physician members in December 2020. It anonymously gathered information on provider demographics, practice-setting characteristics, use of telehealth before and during the pandemic, defined as beginning on March 11, 2020, and provider perceptions of telehealth. A reminder e-mail was sent 1 week after the initial e-mail and the survey was closed 2 weeks after. Participants gave informed consent when they initiated the survey, which on average took 12 min to complete. The survey instrument is available in Supplementary Appendix SA1.

Only physicians who were providing direct patient care with nonmissing data on main outcomes were included (n = 373). The outcomes were use of any (vs. no) live video visits during the pandemic and, among users, the extent of use of live video visits. We queried on the maximum percentage of outpatient visits that were live video telehealth visits since the start of the pandemic. Those who responded 0% were categorized as “No video visits” whereas nonzero response options were categorized as “Any.” The extent of use of live video visits among users were dichotomized into 1–25% (“low users”) and 26–100% (“high users”). We chose this classification based on the low proportion of use relative to in-person visits by obstetricians in a prior national study.3

We compared characteristics of the survey participants with those of the general SMFM membership to assess representativeness of our sample. We ran bivariate analyses to assess the association between the independent variables and the two outcomes using χ2 for categorical variables and t tests for continuous variables. An alpha level p ≤ 0.05 defined statistical significance and was used to select potential independent variables or covariates in the multivariate models. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to quantify the association between each independent variable and each outcome. Following our conceptual model, we ran simultaneous regression models that included combinations of the significant predisposing and enabling variables.

The Akaike information criterion (AIC) helped us select the best fitting model (Model 1). AIC penalizes models with larger numbers of explanatory variables that do not have much explanatory power.17 We performed sensitivity analyses to test the potential contribution of years of obstetric practice, urbanicity, and practice location; although these covariates were not significantly associated with the outcome in bivariate analyses, they were forced into the simultaneous regressions (Model 2). Furthermore, we described the association between the extent of live video visit use among users and provider satisfaction with telehealth and desire for future use, using bivariate analyses. Analyses were performed using Stata IC 16.1.18 Our study was deemed exempt from human subjects review by the Stanford University Research Compliance Office (Protocol no. 56986).

Results

The SMFM has 2,912 associate and regular members, representing about 85% of MFM physicians nationally.19 Survey invitations were sent electronically to 2,573 members with known and active e-mail addresses and they were given 2 weeks to complete; 422 providers responded, for a response rate of 16.4%. After dropping ineligible respondents, the total sample yielded 373 participants from 46 states and Washington D.C.

Demographics of survey respondents are listed in Table 1. Compared with available SMFM membership data, our survey oversampled women, those over age 65, and clinicians working in multiple practice settings; we under sampled clinicians working in university and independent practice settings.

Table 1. Provider Characteristics Associated with Use of Any Live Video Visits During the COVID-19 Pandemic in 2020

CHARACTERISTIC TOTAL SAMPLE n (%) OR MEAN (SE) USE OF LIVE VIDEO VISITS n = 373 pa
NONE n = 46 (12.3%) n (%) OR MEAN (SE) ANY n = 327 (87.7%) n (%) OR MEAN (SE)
Predisposing factors
 Provider demographics
  Age 48.6 (0.6) 52.6 (1.97) 48.1 (0.64) 0.02
  Gender
   Woman 226 (64.9) 21 (55.3) 205 (66.1) 0.19
   Man 122 (35.1) 17 (44.7) 105 (33.9)  
  Years of obstetric practice 16.7 (0.6) 19.0 (2.0) 16.4 (0.6) 0.19
 Practice setting
  Urbanicity
   Urban/large city 231 (65.4) 25 (62.5) 206 (65.8) 0.06
   Suburb near large city 73 (20.7) 5 (12.5) 68 (21.7)  
   Small city or town/rural 49 (13.9) 10 (25.0) 39 (12.5)  
  Comprehensive prenatal care is provided
   No 146 (39.1) 28 (60.9) 118 (36.1) <0.01
   Yes 227 (60.9) 18 (39.1) 209 (63.9)  
  Inpatient care is provided
   No 26 (7.0) 7 (15.2) 19 (5.8) 0.02
   Yes 347 (93.0) 39 (84.8) 308 (94.2)  
  Type of practice setting
   University 174 (46.8) 13 (28.3) 161 (49.4) 0.01
   Community and government 91 (24.5) 12 (26.1) 79 (24.2)  
   Independent 34 (9.1) 6 (13.0) 28 (8.6)  
   Corporate 24 (6.5) 2 (4.4) 22 (6.8)  
   Multiple practice settings 49 (13.2) 13 (28.3) 36 (11.0)  
  % of Medicaid patient caseload
   0–25% 70 (18.9) 12 (26.7) 58 (17.9) 0.23
   26–50% 155 (41.9) 15 (33.3) 140 (43.1)  
   51–75% 107 (28.9) 11 (24.4) 96 (29.5)  
   76–100% 38 (10.3) 7 (15.6) 31 (9.5)  
  Practice location
   Northeast 74 (21.4) 5 (14.3) 69 (22.2) 0.28
   Midwest 69 (19.9) 11 (31.4) 58 (18.7)  
   South 107 (30.9) 9 (25.7) 98 (31.5)  
   West 96 (27.8) 10 (28.6) 86 (27.7)  
  State-level adoption of Medicaid expansion
   Not adopted 85 (24.6) 7 (20.0) 78 (25.1) 0.80
   Adopted but not implemented 10 (2.9) 1 (2.9) 9 (2.9)  
   Adopted and implemented 251 (72.5) 27 (77.1) 224 (72.0)  
Enabling factors
 Telehealth use before COVID-19
  Any remote patient monitoring
   No 229 (61.4) 36 (78.3) 193 (59.0) 0.01
   Yes 144 (38.6) 10 (21.7) 134 (41.0)  
  Any communication using an online patient portal
   No 241 (64.6) 40 (87.0) 201 (61.5) <0.01
   Yes 132 (35.4) 6 (13.0) 126 (38.5)  
  Any remote ultrasound imaging interpretation and consultation
   No 197 (52.8) 33 (71.7) 164 (50.2) 0.01
   Yes 176 (47.2) 13 (28.3) 163 (49.9)  
 Barriers
  State/regional regulations
   No 291 (78.0) 40 (87.0) 251 (76.8) 0.12
   Yes 82 (22.0) 6 (13.0) 76 (23.2)  
  Training providers and staff
   No 233 (62.5) 33 (71.7) 200 (61.2) 0.17
   Yes 140 (37.5) 13 (28.3) 127 (38.8)  
  Provider resistance
   No 280 (75.1) 34 (73.9) 246 (75.2) 0.85
   Yes 93 (24.9) 12 (26.1) 81 (24.8)  
  Institutional/medical group lack of support
   No 309 (82.8) 36 (78.3) 273 (83.5) 0.38
   Yes 64 (17.2) 10 (21.7) 54 (16.5)  
  Setup costs/sustainability
   No 320 (85.8) 41 (89.1) 279 (85.3) 0.49
   Yes 53 (14.2) 5 (10.9) 48 (14.7)  
  Software/hardware usability
   No 210 (56.3) 36 (78.3) 174 (53.2) <0.01
   Yes 163 (43.7) 10 (21.7) 153 (46.8)  
  Reimbursement/insurance coverage
   No 226 (60.6) 34 (73.9) 192 (58.7) 0.05
   Yes 147 (39.4) 12 (26.1) 135 (41.3)  
  Patient’s desire for in-person visit
   No 220 (59.0) 29 (63.0) 191 (58.4) 0.55
   Yes 153 (41.0) 17 (37.0) 136 (41.6)  
  Patient privacy concerns
   No 330 (88.5) 43 (93.5) 287 (87.8) 0.26
   Yes 43 (11.5) 8 (6.5) 40 (12.2)  
  Patient access to internet or data plans
   No 188 (50.4) 36 (78.3) 152 (46.5) <0.0001
   Yes 185 (49.6) 10 (21.7) 175 (53.5)  

Telehealth use prepandemic was reported by one third to almost half of the clinicians, depending on the modality, whereas ∼88% of the clinicians reported any live video use during the pandemic (Table 1). Compared with those who reported no live video visit uptake, users were more likely to be younger (p = 0.02), to provide comprehensive prenatal care (p < 0.01) and/or inpatient care (p = 0.02), practice in university settings (p = 0.01), engage in various telehealth use modalities prepandemic (p ≤ 0.01), and to perceive challenges with software or hardware usability (p < 0.01), reimbursement (p = 0.05) and patient access to the internet or data plans (p < 0.0001).

Any use of live video visits was associated with predisposing and enabling factors (Table 2). Among the predisposing factors, we observed a 1% decrease in use of live video visits for every incremental year in physician age (95% CI = 0.94–1.0) and an almost threefold increase in use among those providing comprehensive prenatal care (crude OR = 2.76; 95% CI = 1.46–5.19) and inpatient care (crude OR = 2.91; 95% CI = 1.15–7.36). Compared with clinicians practicing solely in university settings, clinicians who practiced in multiple settings were far less likely to use live video visits (crude OR = 0.22; 95% CI = 0.10–0.52). Nonetheless, only type of practice setting remained significantly associated with uptake of live video visits when adjusting for significant predisposing and enabling covariates (adjusted OR [aOR] = 0.25; 95% CI = 0.10–0.62) (Model 1, Table 2).

Table 2. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals of Selected Sample Characteristics and Use (vs. No Use) of Live Video Visits During the COVID-19 Pandemic in 2020

CHARACTERISTIC UNADJUSTED OR (95% CI) MODEL 1: aORa (95% CI)b MODEL 2: aORa (95% CI)c
Predisposing factors
 Age 0.97 (0.94–1.00)    
 Years of obstetric practice     0.99 (0.96–1.03)
 Urbanicity      
  Urban/large city     Ref
  Suburb near large city     2.07 (0.66–6.51)
  Small city or town/rural     0.53 (0.19–1.47)
 Comprehensive prenatal care is provided
  No Ref    
  Yes 2.76 (1.46–5.19)    
 Inpatient care is provided
  No Ref    
  Yes 2.91 (1.15–7.36)    
 Type of practice setting
  University Ref Ref Ref
  Community and government 0.53 (0.23–1.22) 0.88 (0.37–2.12) 0.95 (0.33–2.75)
  Independent 0.38 (0.13–1.07) 0.55 (0.18–1.66) 0.64 (0.16–2.62)
  Corporate 0.89 (0.19–4.20) 1.46 (0.29–7.26) 0.57 (0.10–3.36)
  Multiple practice settings 0.22 (0.10–0.52) 0.25 (0.10–0.62) 0.18 (0.06–0.56)
 Practice location
  Northeast     Ref
  Midwest     0.45 (0.13–1.58)
  South     1.33 (0.37–4.76)
  West     0.98 (0.28–3.48)
Enabling factors
 Any RPM before COVID-19
  No Ref    
  Yes 2.50 (1.20–5.21)    
 Any communication using an online patient portal before COVID-19
  No Ref Ref Ref
  Yes 4.18 (1.72–10.14) 3.69 (1.47–9.25) 3.85 (1.33–11.12)
 Any remote ultrasound imaging interpretation and consultation before COVID-19
  No Ref    
  Yes 2.52 (1.28–4.97)    
 Barrier: software/hardware usability
  No Ref Ref Ref
  Yes 3.17 (1.52–6.59) 2.49 (1.14–5.42) 2.28 (0.93–5.62)
 Barrier: reimbursement/insurance coverage
  No Ref    
  Yes 1.99 (1.00–3.99)    
 Barrier: patient access to internet or data plans
  No Ref Ref Ref
  Yes 4.14 (1.99–8.63) 3.47 (1.58–7.60) 5.27 (1.95–14.23)
    AIC = 249.88 AIC = 204.09

Among the enabling factors, use of telehealth before the pandemic increased the odds of any live video use during the pandemic. Specifically, RPM more than doubled the odds (crude OR = 2.5; 95% CI = 1.20–5.21), as did any remote ultrasound imaging interpretation and consultation (crude OR = 2.52; 95% CI = 1.28–4.97); any communication using an online patient portal increased the likelihood fourfold (crude OR = 4.18; 95% CI = 1.72–10.14). Other co-occurring enabling factors that were associated with increased likelihood of live video use were perceived barriers, including software/hardware usability (crude OR = 3.17; 95% CI = 1.52–6.59); reimbursement/insurance coverage (crude OR 1.99; 95% CI = 1.00–3.99); and patient access to internet or data plans (crude OR = 4.14; 95% CI = 1.99–8.63).

After adjusting for type of practice setting and the significant enabling variables—only three enabling factors remained significantly associated with any live video use: any prepandemic communication using an online patient portal (aOR = 3.69; 95% CI = 1.47–9.25); perceived software or hardware usability barriers (aOR = 2.49; 95% CI = 1.14–5.42); and perceived patient access to internet or data plan barriers (aOR = 3.47; 95% CI = 1.58–7.60) (Model 1, Table 2). Model 2 (Table 2) shows that the associations with multiple practice settings and perceived patient access barriers became even stronger when forcing in years of obstetric practice, urbanicity, and practice locations. Model 2 was a better fitting model according to AIC values.

Approximately 44% (n = 143/327) of clinicians who adopted live video visits were high users, defined as conducting >25% of live video visits relative to all visits. The rest (56%) were low users. Type of practice setting was the only predisposing variable associated with high versus low use (Table 3). Compared with clinicians practicing in university settings, who were the highest users, clinicians practicing in community and government settings were less likely to be high users (crude OR = 0.41; 95% CI = 0.23–0.73).

Table 3. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals of Selected Sample Characteristics and the Extent of Use (1–25% vs. 26–100%) Among Live Video Visit Users During the COVID-19 Pandemic in 2020

CHARACTERISTIC UNADJUSTED OR (95% CI) MODEL 1: aORa (95% CI)b MODEL 2: aORa (95% CI)c
Predisposing factors      
 Years of obstetric practice     0.99 (0.97–1.01)
 Urbanicity
  Urban/large city     Ref
  Suburb near large city     0.62 (0.34–1.16)
  Small city or town/rural     0.61 (0.29–1.30)
 Type of practice/setting
  University Ref Ref Ref
  Community and government 0.41 (0.23–0.73) 0.51 (0.28–0.92) 0.58 (0.31–1.11)
  Independent 0.67 (0.30–1.51) 0.78 (0.34–1.78) 0.70 (0.28–1.71)
  Corporate 0.26 (0.09–0.75) 0.34 (0.12–0.99) 0.55 (0.17–1.81)
  Multiple practice settings 0.72 (0.35–1.48) 0.75 (0.36–1.58) 0.89 (0.40–1.99)
 Practice location
  Northeast     Ref
  Midwest     0.46 (0.21–0.98)
  South     0.55 (0.28–1.08)
  West     0.87 (0.43–1.79)
Enabling factors      
 Any communication using an online patient portal before COVID-19
  No Ref    
  Yes 1.77 (1.13–2.78)    
 Any remote ultrasound imaging interpretation and consultation before COVID-19
  No Ref Ref Ref
  Yes 1.80 (1.16–2.80) 1.64 (1.04–2.59) 1.92 (1.17–3.16)
 Barrier: training providers and staff
  No Ref    
  Yes 1.64 (1.05–2.57)    
 Barrier: reimbursement/insurance coverage
  No Ref    
  Yes 1.58 (1.01–2.47)    
 Barrier: patient access to internet or data plans
  No Ref Ref Ref
  Yes 2.20 (1.40–3.44) 1.83 (1.14–2.93) 1.85 (1.12–3.06)
    AIC = 435.57 AIC = 407.62

Enabling factors associated with high versus low use were prepandemic communication using an online patient portal (crude OR = 1.77; 95% CI = 1.13–2.78) and prepandemic use of remote ultrasound imaging interpretation and consultation (crude OR = 1.8; 95% CI = 1.16–2.80). In addition, perceived barriers related to training providers and staff (crude OR = 1.64; 95% CI = 1.05–2.57); reimbursement/insurance coverage (crude OR = 1.58; 95% CI = 1.01–2.47) and patient access to internet or data plans (crude OR = 2.20; 95% CI = 1.40–3.44) about doubled the odds of high versus low use.

In adjusted models, only type of practice setting, prepandemic use of ultrasound imaging interpretation and consultation (aOR = 1.64; 95% CI = 1.04–2.59), and perceived patient access to internet or data plans (aOR = 1.83; 95% CI = 1.14–2.93) remained significantly associated with high versus low use (Model 1, Table 3). When forcing in years of obstetric practice, urbanicity, and practice location, the association with type of practice setting was no longer significant. Instead, a practice located in the Midwest (vs. the Northeast) showed lower odds of high adoption (aOR = 0.46; 95% CI = 0.21–0.98) (Model 2, Table 3). Model 2 was a better fitting model according to the AIC values.

Among live video visit users, high users were more likely to strongly agree that services through telehealth are excellent, whereas low users tended to disagree, be neutral or not strongly agree (p < 0.01) (Table 4). Similarly, high users were far more likely than low users to strongly agree that “telehealth is a positive thing for my clinic” (p < 0.001). Although most clinicians reported that they wanted to continue offering live video telehealth services after the pandemic ends or relaxes, more high users had this wish (92% vs. 99%; p < 0.01).

Table 4. Measures of Provider Satisfaction and Desire for Future Use Associated with the Extent of Use Among Live Video Visit Users

CHARACTERISTIC AMONG USERS: MAXIMUM % OF OUTPATIENT VISITS THAT WERE LIVE VIDEO VISITS SINCE THE START OF THE COVID-19 PANDEMIC
1–25% n = 184 (56.3%) n (%) 26–100% n = 143 (43.7%) n (%) pa
Provider satisfaction
 Overall, I would rate services through telehealth as excellent
  Strongly disagree 8 (4.6) 5 (3.6) <0.01
  Disagree 17 (9.8) 10 (7.3)  
  Neutral 46 (26.4) 28 (20.3)  
  Agree 77 (44.3) 45 (32.6)  
  Strongly agree 26 (14.9) 50 (36.2)  
 Overall, I believe telehealth is a positive thing for my clinic
  Strongly disagree 6 (3.5) 5 (3.6) <0.001
  Disagree 5 (2.9) 1 (0.7)  
  Neutral 24 (14.0) 9 (6.5)  
  Agree 80 (46.8) 43 (31.2)  
  Strongly agree 56 (32.8) 80 (58.0)  
Future use
 Desire to continue offering live video telehealth services once COVID-19 restrictions have been relaxed or lifted
  No or unsure 14 (7.8) 1 (0.7) <0.01
  Yes 166 (92.2) 141 (99.3)  

Discussion

This survey found that as of December 2020 there was widespread telehealth use among practicing MFM clinicians. This finding is consistent with previous surveys of telehealth use among practicing obstetric care providers.3,4 Furthermore, we found that 44% of practicing clinicians were high users defined as using live videos for at least 25% of all visits and that 9% used live videos for >75% of all visits. A previous survey of practicing obstetricians showed that only 9% were using telehealth for >50% of their total visits in June 2020, corroborating the higher use among MFM clinicians compared with other obstetric care providers.3 Despite the higher use among MFM clinicians, the majority employed it in no more than one out of four visits. This pattern suggests a selective use with patients, perhaps to provide closer monitoring for patients with complex pregnancies, such as gestational diabetes or pre-eclampsia, or patients with geographic barriers to in-person care.

Our multivariable models showed that several predisposing and enabling factors were associated with any live video visit use during the pandemic. For example, the higher likelihood of use among clinicians in practices that communicated through patient portals may indicate a more complex electronic health record system, such as Epic, which facilitates easier integration of live video visits into their workflow.20 Evidence further suggests that digital modes of communication are most effective for patients and clinicians who have already established relationships incorporating flexible use of telecommunication.21

When adjusting for covariates, clinicians who used live video visits (vs. no use) were more likely to perceive barriers to software and/or hardware, which could include challenges integrating this technology into existing clinical workflows such as rooming. In addition, clinicians who used live video visits were more likely to perceive patient barriers to access the internet or data plans due to lack of high-speed internet connectivity or a HIPAA-compliant videoconferencing platform. These results indicate that perceived technical barriers were important drivers of telehealth use among clinicians. Studies of patient perceptions corroborate provider perceptions of patient barriers: patients commonly report internet or mobile data access barriers; however, patients also perceive advantages to using telehealth such as reduced travel and childcare expenditures and time away from work.22

Notably, only perceived patient barriers remained significant concerns after forcing in years of obstetric practice, urbanicity, and practice location. In contrast, perceived reimbursement barriers, found to be important barriers in other studies,23 were not associated with live video use in our models, perhaps because telehealth insurance coverage expanded considerably during the pandemic.24 The main deterrent of use was the type of practice setting. Clinicians who practiced in multiple settings were far less likely to adopt live video use perhaps because of the temporary nature of their assignments or the difficulty in learning multiple systems.

Type of practice setting also influenced the amount of use of live video visits among adopters. High (vs. low) users were far more likely to practice in university settings than in community or government settings, as did clinicians who engaged in prepandemic use of ultrasound imaging interpretation and counseling. University-based MFM providers—who are more abundant in the Northeast—and those who provide remote ultrasound interpretation usually are part of larger health care systems with more widespread technological support. Furthermore, the likelihood of high use was almost double among clinicians who perceived internet access barriers among their patients, suggesting that the perception of patient access barriers increases with more telehealth use.

Finally, high users are more likely to have positive attitudes toward telehealth use and to want to continue using it in the future. Provider satisfaction and experience are important quality indicators in health care.25 Provider advantages such as improved continuity of care with patients facing challenges to attend office visits, flexible scheduling, increased clinical support for local providers caring for high-risk patients, expanding the reach to underserved areas, and reducing overhead costs associated with in-person visits are some advantages of telehealth identified by SMFM.26 Whether telehealth services are maintained at the same level after the pandemic will require ongoing investigation; however, there may be utility in expanding the use of hybrid models combining in-person and telehealth visits.

STRENGTHS AND LIMITATIONS

Strengths of this study include the geographic diversity and variety of clinical practice settings of the respondents and the rich array of variables included in our multivariate models. Among limitations, although our response rate was similar to other recent physician online surveys,19,27 the 16.4% response rate for this survey was low, potentially contributing to selection bias. In addition, although MFM providers generally care for pregnant persons considered to be “high-risk,” it is unknown whether clinicians preferentially applied telehealth to low-risk or high-risk patients, or both. Our study was limited to in-depth understanding of usage of live video visits; change across other telehealth modalities has not been thoroughly examined.

Moreover, we did not assess the patient perspective, nor provider perceptions of perceived patient safety or privacy and security concerns or cost-related factors as potential barriers to use. During a pandemic when prenatal care practices are suddenly modified, pregnant women may feel abandoned and miss face-to-face encounters with their providers. Furthermore, the cross-sectional study design only captured one given moment, and conditions have changed throughout the pandemic. There is need for follow-up research that is longitudinal, especially given the rapidly changing health care delivery environment and includes pregnancy outcomes of pregnant persons who received prenatal care through telehealth.

IMPLICATIONS

Our study demonstrates that digital telehealth infrastructure is a critical enabler of virtual patient care during the pandemic. Moreover, providing obstetric care through telehealth is associated with ample SMFM clinician satisfaction and MFMs with high utilization are interested in continuing telehealth use postpandemic, potentially improving access to care and working to eliminate disparities. Key perceived barriers to telehealth use identified by SMFM clinicians signal opportunities for advocacy efforts by obstetricians at the state and national levels.

Future studies should identify how these barriers affect start-up of new programs and expansion of existing telehealth programs. Advocacy to promote expansion of telehealth include addressing barriers to access, such as the “digital divide” and safety net provider capacity limitations, by bolstering access to the internet, smartphones, and data plans in communities. In addition, providing grants and technical assistance to safety net providers can increase their capacity to provide telehealth services.15

Ongoing research is needed to help guide providers on when and how to implement telehealth along the maternal-newborn health care continuum28 in both inpatient and outpatient settings.20 Since telehealth has not been equitably practiced in underserved communities, exacerbating inequalities, efforts should be made to overcome barriers, such as internet access or smartphone availability. Our cross-sectional study compared pre- and postpandemic telehealth use. Prospective studies measuring provider use and satisfaction with telehealth could overcome retrospective bias. Finally, more research is required to elucidate the patient perspective and clarify what barriers patients face in accessing telehealth resources.

Conclusions

Live virtual visits have been widely used by MFM clinicians providing care during the pandemic. Although this telehealth modality enjoys ample satisfaction and is likely to be continued postpandemic, additional studies are warranted to study optimal patient populations and effectiveness of virtual prenatal and postnatal care.

Acknowledgments

The authors would like to thank the SMFM Clinical Informatics Committee and Virginia Andrews, SMFM for supporting this study. The authors would also like the thank the Wallace Center for Maternal, Child and Adolescent Health for partially funding this study and Dr. Maureen Lahiff, School of Public Health, University of California, Berkeley for her support with planning the data analysis.

Authors’ Contributions

Conceptualization (lead), methodology (lead), writing—original draft (lead), supervision (lead), formal analysis (supporting), funding acquisition (lead), and review and editing (equal) by S.G. Formal analysis (lead), visualization (lead), data curation (supporting), project administration (lead), and review and editing (equal) by G.N.K. Formal analysis (supporting), visualization (supporting), and review and editing (equal) by G.I.C. Conceptualization (supporting), resources (supporting), data curation (lead), formal analysis (supporting), and review and editing (equal) by P.C.T. Conceptualization (supporting), resources (lead), formal analysis (supporting), and review and editing (equal) by S.H.S.

Disclosure Statement

No competing financial interests exist.

Funding Information

This study was partially funded by the Wallace Center for Maternal, Child and Adolescent Health Center at UC Berkeley. The sponsor funds projects consistent with its mission, giving academic freedom to investigators to design studies, collect, analyze, and interpret data and publish their study.

Supplementary Material

Supplementary Appendix SA1

REFERENCES

  • 1. Lister R, Osarhiemen O, Robinson M, et al. The silver lining to Covid-19: Access to obstetric care via telehealth. Am J Obstet Gynecol 2021;224(2):S595–S595. Crossref, MedlineGoogle Scholar
  • 2. Mallampati D, Talati A, Menard MK. Provider and Practice-Based Perceptions of Telehealth and Prenatal Care [Internet]. University of North Carolina at Chapel Hill: Chapel Hill, NC, USA; 2020. Available from: https://maternalhealthlearning.org/telehealth/reports/ (Last accessed: March 15, 2021]. Google Scholar
  • 3. Weigel G, Frederiksen B, Ranji U, et al. How OBGYNs Adapted Provision of Sexual and Reproductive Health Care During the COVID-19 Pandemic [Internet]. Kaiser Family Foundation; 2020. Available from: https://www.kff.org/womens-health-policy/issue-brief/how-obgyns-adapted-provision-of-sexual-and-reproductive-health-care-during-the-covid-19-pandemic/ [Last accessed: March 15, 2021]. Google Scholar
  • 4. Mallampati D, Talati AN, Honart AW, et al. Preferences and perceived needs for telehealth use among maternity care providers nationally. Am J Obstet Gynecol 2021;224(2):S602. CrossrefGoogle Scholar
  • 5. Implementing telehealth in practice: ACOG committee opinion summary, number 798. Obstet Gynecol 2020;135(2):493–494. Crossref, MedlineGoogle Scholar
  • 6. DeNicola N, Grossman D, Marko K, et al. Telehealth interventions to improve obstetric and gynecologic health outcomes: A systematic review. Obstet Gynecol 2020;135(2):371–382; doi: 10.1097/AOG.0000000000003646. Crossref, MedlineGoogle Scholar
  • 7. Pflugeisen BM, Mou J. Patient satisfaction with virtual obstetric care. Matern Child Health J 2017;21(7):1544–151; doi: 10.1007/s10995-017-2284-1. Crossref, MedlineGoogle Scholar
  • 8. Peahl AF, Powell A, Berlin H, et al. Patient and provider perspectives of a new prenatal care model introduced in response to the coronavirus disease 2019 pandemic. Am J Obstet Gynecol 2021;224(4):384.e1–384.e11. Crossref, MedlineGoogle Scholar
  • 9. Hwang YP, Kothmann MM, Berry MJ, et al. Patient satisfaction with telehealth visits: A contemporary study in the obstetrical population. Am J Obstet Gynecol 2021;224(2):S658. CrossrefGoogle Scholar
  • 10. Leighton C, Conroy M, Bilderback A, et al. Implementation and impact of a maternal–fetal medicine telemedicine program. Am J Perinatol 2019;36(07):751–758; doi: 10.1055/s-0038-1675158. Crossref, MedlineGoogle Scholar
  • 11. Xie W, Dai P, Qin Y, et al. Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: An updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy Childbirth 2020;20(1):198; doi: 10.1186/s12884-020-02892-1. Crossref, MedlineGoogle Scholar
  • 12. Weigel G, Ramaswamy A, Sobel L, et al. Opportunities and Barriers for Telemedicine in the U.S. During the COVID-19 Emergency and Beyond [Internet]. Kaiser Family Foundation; 2020. Available from: https://www.kff.org/womens-health-policy/issue-brief/opportunities-and-barriers-for-telemedicine-in-the-u-s-during-the-covid-19-emergency-and-beyond/ [Last accessed: May 11, 2020]. Google Scholar
  • 13. Lee NT, Karsten J, Roberts J. Removing regulatory barriers to telehealth before and after COVID-19 [Internet]. Brookings Institution: Washington, DC, USA; 2020. Available from: https://www.brookings.edu/research/removing-regulatory-barriers-to-telehealth-before-and-after-covid-19/ [Last accessed: June 17, 2021]. Google Scholar
  • 14. Alves DS, Times VC, da Silva ÉMA, et al. Advances in obstetric telemonitoring: A systematic review. Int J Med Inform 2020;134:104004; doi: 10.1016/j.ijmedinf.2019.104004. Crossref, MedlineGoogle Scholar
  • 15. Okoroh EM, Kroelinger CD, Smith AM, et al. US and territory telemedicine policies: Identifying gaps in perinatal care. Am J Obstet Gynecol 2016;215(6):772.e1–772.e6; doi: 10.1016/j.ajog.2016.08.020. Crossref, MedlineGoogle Scholar
  • 16. Hill I, Burroughs E. Maternal Telehealth Has Expanded Dramatically during the COVID-19 Pandemic: Equity Concerns and Promising Approaches [Internet]. Urban Institute & Robert Wood Johnson Foundation; 2020. Available from: https://www.urban.org/research/publication/maternal-telehealth-has-expanded-dramatically-during-covid-19-pandemic [Last accessed: March 15, 2021]. Google Scholar
  • 17. Konishi S, Kitagawa G. Information Criteria and Statistical Modeling. New York: Springer Science & Business Media; 2008. Google Scholar
  • 18. Stata Statistical Software: Release 16. StataCorp LLC: College Station, TX, USA, 2019. Google Scholar
  • 19. Lappen JR, Vricella LK, Andrews V, et al. Society for Maternal-Fetal Medicine Special Statement: Maternal-fetal medicine subspecialist survey on abortion training and service provision. Am J Obstet Gynecol 2021;225(1):B2–B11. Crossref, MedlineGoogle Scholar
  • 20. Zork NM, Aubey J, Yates H. Conversion and optimization of telehealth in obstetric care during the COVID-19 pandemic. Semin Perinatol 2020;44(6):151300; doi: 10.1016/j.semperi.2020.151300. Crossref, MedlineGoogle Scholar
  • 21. Ignatowicz A, Atherton H, Bernstein CJ, et al. Internet videoconferencing for patient–clinician consultations in long-term conditions: A review of reviews and applications in line with guidelines and recommendations. Digit Health 2019;5:2055207619845831; doi: 10.1177/2055207619845831. CrossrefGoogle Scholar
  • 22. Bidmead E, Lie M, Marshall A, et al. Service user and staff acceptance of fetal ultrasound telemedicine. Digit Health 2020;6:2055207620925929; doi: 10.1177/2055207620925929. CrossrefGoogle Scholar
  • 23. Olson CA, McSwain SD, Curfman AL, et al. The current pediatric telehealth landscape. Pediatrics 2018;141(3):e20172334. Crossref, MedlineGoogle Scholar
  • 24. Volk J, Palanker D, O’Brien M, et al. States’ Actions to Expand Telemedicine Access During COVID-19 and Future Policy Considerations [Internet]. Commonwealth Fund; 2021. Available from: https://doi.org/10.26099/r95z-bs17 [Last accessed: May 10, 2022]. Google Scholar
  • 25. Bhandari N, Payakachat N, Fletcher D et al. Validation of newly developed surveys to evaluate patients’ and providers’ satisfaction with telehealth obstetric services. Telemed J E Health 2020;26(7):879–888; doi: 10.1089/tmj.2019.0156. LinkGoogle Scholar
  • 26. Telehealth: Opportunities to Increase Access to Quality Health Care and Advance Equitable Maternal Health [Internet]. Society for Maternal-Fetal Medicine; 2020. Available from: https://s3.amazonaws.com/cdn.smfm.org/media/2633/December_2020_Issue_Brief__Telehealth.pdf [Last accessed: May 10, 2022]. Google Scholar
  • 27. Park HY, Kwan YM, Jun HR et al. Satisfaction survey of patients and medical staff for telephone-based telemedicine during hospital closing due to Covid-19 transmission. Telemed J E Health 2021;22(7):724–732; doi: 10.1089/tmj.2020.0369. LinkGoogle Scholar
  • 28. Galle A, Semaan A, Huysmans E, et al. A double-edged sword—Telemedicine for maternal care during COVID-19: Findings from a global mixed-methods study of healthcare providers. BMJ Glob Health 2021;6(2):e004575. Crossref, MedlineGoogle Scholar





Source link